Broadfin Capital as of Dec. 31, 2019
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 38 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 19.0 | $142M | 440k | 321.86 | |
| iShares Russell 2000 Index (IWM) | 17.8 | $133M | 800k | 165.67 | |
| Biohaven Pharmaceutical Holding | 7.4 | $55M | 1.0M | 54.44 | |
| SPDR S&P Biotech (XBI) | 4.5 | $33M | 350k | 95.11 | |
| BioDelivery Sciences International | 3.6 | $27M | 4.3M | 6.32 | |
| Alkermes (ALKS) | 3.4 | $25M | 1.2M | 20.40 | |
| Viewray (VRAYQ) | 3.1 | $24M | 5.6M | 4.22 | |
| Amarin Corporation (AMRN) | 3.0 | $23M | 1.0M | 21.44 | |
| Quotient | 2.5 | $19M | 2.0M | 9.51 | |
| Eiger Biopharmaceuticals | 2.5 | $18M | 1.2M | 14.90 | |
| STAAR Surgical Company (STAA) | 2.2 | $16M | 462k | 35.17 | |
| Intersect Ent | 2.1 | $16M | 631k | 24.90 | |
| Progenics Pharmaceuticals | 2.1 | $16M | 3.1M | 5.09 | |
| Nanostring Technologies (NSTGQ) | 2.1 | $16M | 556k | 27.82 | |
| Iovance Biotherapeutics (IOVA) | 2.0 | $15M | 533k | 27.68 | |
| Dermira | 1.8 | $14M | 896k | 15.16 | |
| Recro Pharma (SCTL) | 1.8 | $13M | 721k | 18.33 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $13M | 618k | 20.51 | |
| Vapotherm | 1.6 | $12M | 1.0M | 12.16 | |
| Sientra | 1.5 | $12M | 1.3M | 8.94 | |
| Vericel (VCEL) | 1.4 | $11M | 620k | 17.40 | |
| La Jolla Pharmaceuticl Com Par | 1.4 | $11M | 2.7M | 3.93 | |
| Alexion Pharmaceuticals | 1.2 | $9.0M | 83k | 108.15 | |
| Sol Gel Technologies (SLGL) | 1.2 | $8.9M | 522k | 17.15 | |
| Relmada Therapeutics (RLMD) | 1.1 | $8.6M | 221k | 39.00 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $8.1M | 400k | 20.26 | |
| Flamel Technologies Sa (AVDL) | 1.0 | $7.8M | 1.0M | 7.55 | |
| Exicure | 1.0 | $7.7M | 2.7M | 2.86 | |
| Zogenix | 0.9 | $7.0M | 135k | 52.13 | |
| ICU Medical, Incorporated (ICUI) | 0.8 | $5.6M | 30k | 187.13 | |
| Luminex Corporation | 0.6 | $4.8M | 208k | 23.16 | |
| Strata Skin Sciences (SSKN) | 0.5 | $3.8M | 1.8M | 2.08 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $3.6M | 1.9M | 1.89 | |
| Anaptysbio Inc Common (ANAB) | 0.5 | $3.6M | 222k | 16.25 | |
| Mylan Nv | 0.4 | $3.0M | 150k | 20.10 | |
| Heron Therapeutics (HRTX) | 0.3 | $2.1M | 90k | 23.50 | |
| Scynexis | 0.2 | $1.8M | 2.0M | 0.91 | |
| Palatin Technologies | 0.1 | $817k | 1.0M | 0.78 |
